EHMT2 and non-small cell lung carcinoma: Among the emerging epigenetic targets, the histone methyltransferase G9a, encoded by the Euchromatic Histone-Lysine N-methyltransferase-2 (EHMT2), has shown to be a relevant target in NSCLC [11].